Fig. 3From: Health care resource use among patients with advanced non-small cell lung cancer: the PIvOTAL retrospective observational studyHospitalizations resulting from a grade 3–5 AE during first- and second-line therapy. 1L, 2L, first- and second-line therapy; AE, adverse eventBack to article page